B2B Leap Partners
Investing in pioneering B2B solutions that use advanced platforms to rethink conventional business processes and strategies.
- SaaS
- Other
Browse 797 venture capital firms headquartered in Boston. Median check across the 784 firms that disclose a range is $500K–$2.5M; most active at Seed, Pre-Seed, Series A; concentrated in SaaS, AI / ML, Healthcare. Every firm is verified — explore their thesis, check size, and portfolio, then get matched with the best-fit investors for your startup.
Investing in pioneering B2B solutions that use advanced platforms to rethink conventional business processes and strategies.
Investing in transformative B2B SaaS solutions that empower business operations.
B2B Tech Catalysts is a micro-fund concentrating on B2B SaaS and enterprise solutions shaping the next generation of business software.
Crypto and digital asset infrastructure investor that can be relevant when settlement verification, signed records, and programmable money movement overlap with crypto rails.
Invests in early-stage software/fintech with strong emphasis on scalable go-to-market and enterprise outcomes.
BankTech Rising Fund invests exclusively in early-stage startups modernizing legacy banking systems, with specific emphasis on compliance tech and AI-driven tools.
Baruch Future Ventures focuses on transformational companies in synthetic biology and the biologically-enabled industries.
Specializes in early-stage investments in B2B software companies solving operational inefficiencies, such as AI for enterprise project management and risk prediction.
Battery Ventures is a stage-agnostic global tech investor backing founders building category-defining companies in application software, infrastructure software, consumer tech, and industrial tech + l...
Invests in early-stage technology companies with a strong focus on HealthTech and enterprise SaaS solving critical operational problems.
Invests in early-stage HealthTech and SaaS companies leveraging data and technology to improve healthcare workflows.
Micro-fund prioritizing lean, scalable AI-first enterprise tools with early-stage funding.
Dedicated entirely to early-stage pharma and biotech innovation, with focus on enabling technologies for the future of healthcare.
Binary Builders invests in the next generation of software tooling with a primary focus on AI-powered development platforms.
Focused on investing in early-stage startups innovating in lab automation and life science tools, with a particular interest in technologies that enhance research productivity.
Investing exclusively in healthcare and biotech innovations, with a focus on robotics and cloud-based tech for pharma and diagnostics.
Focuses on early-stage investments in breakthrough biological and computational technologies for healthcare.
Focuses on early-stage investments in HealthTech and B2B SaaS companies that innovate the healthcare industry with AI solutions.
Focused on uncovering breakthrough Biotech startups solving critical industry challenges.
Investing in transformative medtech startups developing novel clinical solutions, particularly in prosthetics and rehabilitation.
Invests in early-stage companies developing groundbreaking biotech and regenerative medicine solutions.
Focused exclusively on investing in startups that innovate with biomarkers to improve preventive health outcomes.
Early-stage fund dedicated to microbiome innovation, funding transformative health solutions targeting specific microbiota like oral health.
Invests in AI and hardware innovations that enhance human-machine interactions through advanced biomechanics technologies.
Showing 97–120 of 797 firms — page 5 of 34.